|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
CME | Carey Charles P | Director | Feb 10 | Sale | 244.36 | 3,000 | 733,072 | 7,675 | Feb 14 08:41 PM |
CME | Carey Charles P | Director | Aug 10 | Sale | 164.51 | 6,000 | 987,060 | 8,141 | Aug 12 06:14 PM |
CME | Carey Charles P | Director | Aug 11 | Sale | 168.01 | 2,000 | 336,020 | 6,141 | Aug 12 06:14 PM |
CME | Carey Charles P | Director | May 07 | Sale | 179.29 | 6,000 | 1,075,740 | 18,141 | May 09 12:51 PM |
CME | Carey Charles P | Director | May 08 | Sale | 178.62 | 4,000 | 714,480 | 14,141 | May 09 12:51 PM |
CME | Carey Charles P | Director | Nov 20 | Sale | 191.64 | 3,000 | 574,920 | 26,141 | Nov 23 09:58 AM |
CME | Carey Charles P | Director | Nov 21 | Sale | 192.15 | 2,000 | 384,300 | 24,141 | Nov 23 09:58 AM |
CME | Carey Charles P | Director | Nov 02 | Sale | 183.45 | 2,800 | 513,660 | 1,532 | Nov 06 05:47 PM |
CME | Carey Charles P | Director | Feb 21 | Sale | 290.64 | 1,200 | 348,768 | 5,532 | Feb 22 04:33 PM |
CME | Carey Charles P | Director | Feb 22 | Sale | 289.79 | 993 | 287,761 | 4,539 | Feb 22 04:33 PM |
CME | Carey Charles P | Director | Sep 21 | Buy | 304.60 | 1 | 305 | 1 | Oct 14 04:40 PM |
CME | Carey Charles P | Director | Oct 12 | Buy | 297.79 | 1 | 298 | 1 | Oct 14 04:40 PM |
CME | Carey Charles P | Director | May 26 | Sale | 301.60 | 500 | 150,800 | 5,977 | May 28 07:17 PM |
CME | Carey Charles P | Director | Apr 29 | Sale | 226.53 | 2,000 | 453,070 | 6,477 | May 01 03:25 PM |
CME | Carey Charles P | Director | Nov 04 | Sale | 320.99 | 2,000 | 641,980 | 8,477 | Nov 06 04:45 PM |
CME | Carey Charles P | Director | Apr 24 | Sale | 487.52 | 900 | 438,768 | 10,511 | Apr 29 05:45 PM |
CME | Carey Charles P | Director | Apr 25 | Sale | 479.99 | 200 | 95,998 | 10,311 | Apr 29 05:45 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite